FTC cracks down on CBD health claims
RANDY HUTCHINSON
The FTC often assigns catchy names to its enforcement actions. It went after illegal robocallers in Operation Call It Quits. Operation Game of Loans was a crackdown on student loan modification scams.
In a recently announced law enforcement sweep called Operation CBDeceit, the agency reached settlements with six companies it alleged were making unsupported claims about the ability of their CBD products to treat serious health conditions, including cancer, diabetes and autism. Some companies also claimed that their products were more effective at treating pain than OxyContin and other prescription medications. The companies’ products include oils, coffees, creams, sprays and gummies.
To embed, copy and paste the code into your website or blog:
Welcome to Wiley’s update on recent developments and what’s next in consumer protection at the Consumer Financial Protection Bureau (CFPB) and Federal Trade Commission (FTC). In this newsletter, we analyze recent regulatory announcements, recap key enforcement actions, and preview upcoming deadlines and events. We also include links to our articles, blogs, and webinars with more analysis in these areas. We understand that keeping on top of the rapidly evolving regulatory landscape is more important than ever for businesses seeking to offer new and ground-breaking technologies.
Regulatory Announcements
CBD and Hemp Legal and Regulatory Roundup – March 2021 #1 | Kelley Drye & Warren LLP jdsupra.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from jdsupra.com Daily Mail and Mail on Sunday newspapers.
Editorial credit: Felix Lipov / Shutterstock.com According to a Federal Trade Commission official, settlements in a law enforcement sweep against CBD marketers send a clear message to the growing sector: Don’t make spurious health claims that are unsupported by medical science.
A handful of marketers of CBD products have agreed to each pay tens of thousands of dollars to the Federal Trade Commission after they were charged with making deceptive claims.
Dubbed “Operation CBDeceit,” the sweep of actions against six sellers of CBD-containing products highlights “the first law enforcement crackdown on deceptive claims” in the CBD market, according to the government agency in a Dec. 17 news release. The sweep also reflects the FTC’s ongoing efforts to protect consumers from deceptive, false and misleading health claims in advertisements on websites and via social media.
U.S. Federal Trade Commission Lays Down the Law on Deceptive CBD Claims December 18, 2020 Contact Author Rachel Grabenhofer
Close
Sponsored
The U.S. Federal Trade Commission (FTC) announced its first law enforcement crackdown on deceptive claims in the growing market for cannabidiol (CBD) products. Oils, balms, gummies, coffee and other goods were among the product types cited.
The FTC reports it is taking action against six sellers of CBD-containing products for making a wide range of scientifically unsupported claims about the products abilities to treat serious health conditions including cancer, heart disease, hypertension, Alzheimer’s disease and others.
The agency is requiring each of the companies and individuals behind them to stop making these unsupported claims immediately, and several will pay monetary judgments. The orders settling the FTC’s complaints also bar the respondents from similar deceptive advertising in the future, and require them to